$NXTS

$1.77▲ +27.3% YTD

4 SEC 13D/G filings tracked · Last updated Oct 7, 2026

Filing History

News

NXTS ▲ +27.3% - Nexentis Technologies Inc.

CP $1.77▲ +27.3%Oct 7, 2026 · ThinkSabio Blog

$NXTS - Nexentis: MitoCareX Bio Deploys its Computational Drug Discovery Infrastructure on Google Cloud…

News

NXTS ▲ +16.5% - Nexentis Technologies Inc.

CP $1.55▲ +16.5%Sep 24, 2026 · ThinkSabio Blog

$NXTS - Nexentis: MitoCareX Strengthens Its Computational Drug Discovery Capabilities with Appointment of Prof. Dan T. Major to Scientific Advisory Bo…

News

NXTS ▲ +10.6% - Nexentis Technologies Inc.

CP $1.56▲ +10.6%Sep 23, 2026 · ThinkSabio Blog

$NXTS - Nexentis: MitoCareX Evaluates Expanded Protein Capabilities to Enhance Flexibility and Support Future Drug Discovery…

SEC 13D/G

$NXTS SEC Filing Update (15-JUL-2026) | ThinkSabio - Stocks Simplified

$2.50▼ -77.54%Jul 15, 2026 · ThinkSabio Blog

$NXTS SEC 13D/G institutional ownership filing. Materials sector. SEC Filing Update: #NXTS : $2.50 Sector: Materials | YTD: 🔽 -77.54% The SEC disclose…